Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study.
Wang X, Wang Y, Yong X, Wu B, Sun Z, Lou N, Wen Q, Zhang Y, Li S, Li J, He Y, Cheng J, Zhong X, Shen J, Yang W.
Wang X, et al. Among authors: wen q.
J Diabetes. 2022 Dec;14(12):822-830. doi: 10.1111/1753-0407.13337. Epub 2022 Dec 14.
J Diabetes. 2022.
PMID: 36515221
Free PMC article.
Clinical Trial.